Efficacy of Palivizumab Prophylaxis Among Infants With Congenital Heart Disease: A Case Control Study


Ozyurt A. , NARİN N. , BAYKAN A. , Argun M. , PAMUKÇU Ö. , ZARARSIZ G. , ...Daha Fazla

PEDIATRIC PULMONOLOGY, cilt.50, ss.1025-1032, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 50 Konu: 10
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/ppul.23102
  • Dergi Adı: PEDIATRIC PULMONOLOGY
  • Sayfa Sayıları: ss.1025-1032

Özet

Background: Palivizumab prophylaxis for RSV has been consistently reported to reduce the risk of hospital admissions related to RSV infection in children with symptomatic cardiac disease. This study was designed to investigate the efficacy of palivizumab prophylaxis among infants with congenital heart disease (CHD) in Turkey.